Author:
Ren Shengxiang,Chen Xiaoxia,Kuang Peng,Zheng Limou,Su Chunxia,Li Jiayu,Li Bing,Wang Yongshen,Liu Lu,Hu Qiong,Zhang Jie,Tang Liang,Li Xuefei,Zhou Caicun,Schmid-Bindert Gerald
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of Anti‐Breast Cancer Thiophene Sulfonamide Derivatives: Design, Synthesis, Molecular Docking against EGFR, MM‐PBSA, MD Simulations, ADME/Tox, and in vitro Studies;ChemistrySelect;2023-07-19
2. Social determinants of sex disparities in cancer in Southeast Asia;iScience;2023-07
3. Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-07-12
4. Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405);International Journal of Clinical Oncology;2022-06-20
5. Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial;European Journal of Cancer;2021-05